Clinical Trial Update: Pembro/Carbo/Taxol in Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pembrolizumab, carboplatin, and paclitaxel in endometrial cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Daniela Matei, MD | Conditions: Endometrial Cancer, Endometrial Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-11-30